About this event
Join us on Thursday, September 22, at 1 pm ET. Dr. Jeffrey Cummings will discuss drug development and the changing Alzheimer's Disease therapeutic landscape. Dr. Cummings will review in great length the following key items:
Ms. Jeanine Falinski, VP of Strategy and Corporate Development, has more than 20 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing, later on receiving her MBA in Pharmaceutical Management from Drexel University.
We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.
Share this event